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Abstract
Background: Fine needle aspiration biopsy (FNAB) is gaining increasing popularity in the diagnosis
of musculoskeletal lesions; and in many patients, a definitive diagnosis can be rendered from
aspiration smears alone. Its applicability in bone pathology, however, has been controversial due to
a high percentage of inadequate smears, difficulty in evaluation of tissue architecture and
nonspecific results in the diagnosis of primary bone lesions. In this study, the value of aspiration as
the first pathological investigation in the diagnosis of a bone lesion was evaluated.
Methods: 91 cases of clinically suspected cases of bone lesions were aspirated over a period of
two years. Direct or cytospin smears were fixed in 95% alcohol and stained by Hematoxylin and
Eosin or air-dried and later fixed in methanol for May Grnwald Giemsa staining.
Results: Of the 91 patients who were subjected to FNAB, 81 were considered satisfactory and
10.9 % (10) were inadequate\inconclusive for diagnosis. Cyto-histological concordance was
obtained in 78.5 % (51/65) patients. Positive and negative predictive values were 87.5% and 97.2 %
respectively. Sensitivity as a preliminary diagnostic technique was 93.3%, whereas specificity was
94.5 %. Overall, diagnostic accuracy was 94.2 %. Metastatic lesions were detected with 100%
accuracy. Two cases were reported as false positive and one case as false negative.
Conclusion: Cytology provides valuable information to the clinician to make an informed decision
regarding appropriate therapy. We conclude that time-consuming and costly investigations may be
reduced by choosing FNAB as the initial pathological diagnostic method for skeletal lesions of
unknown origin. The choice of radiological examinations, laboratory tests and surgical biopsies can
be determined after the FNAB diagnosis.
Background
Fine needle aspiration biopsy (FNAB) has established its
role in the preliminary diagnosis and planning of therapy
for lesions in organs like thyroid, breast, lymph nodes and
even the skull [1]. It, however, plays a limited role in
detection of bone lesions. This may be attributed to lack
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of experience of the cytological appearance of bone
lesions, which in turn, is due to difficulty associated with
aspiration [2].
For long, widespread usage of FNAB as a diagnostic tool
has been impeded because of the requirement of consid-
erable training and experience of the cytopathologist as
well as limited clinical information, false negative and
false positive diagnoses and the overlap of cytological fea-
tures in benign and malignant lesions. Often diagnosis of
benign lesions cannot be made with certainty. Precise
classification of a tumor is difficult on the basis of FNAB
alone and histopathological confirmation is frequently
required. However, on the other hand, FNAB of bone
lesions has its own advantages of being simple, safe, and
inexpensive and a quick outpatient procedure. It can also
be repeated at different sites in case of inadequate material
being aspirated [3].
This study was undertaken to assess the accuracy of FNAB
and histopathological correlation in the diagnosis of bone
lesions. Special emphasis was given to understanding its
limitations and diagnostic aberrations. Analysis of the dis-
cordant cases was done to determine the source of diag-
nostic errors. A review of literature was done to compare
the results with those of previous workers.
Materials and methods
This study was conducted by the department of Pathology
in conjunction with the department of Orthopedics, Moti
Lal Nehru Medical College, Allahabad, India at the tertiary
referral center: the Swaroop Rani Nehru Hospital. 91 cases
were referred for FNAB in clinically suspected bone
lesions.
A detailed clinical workup, including radiological assess-
ment (X-ray and/or CT scan), was done prior to FNAB.
The site of aspiration was approached through the short-
est distance with radiological guidance. Aspirates were
obtained using disposable needles (22–24 G) attached to
a disposable 10 ml plastic syringe. A Cameco-type syringe
holder was used where necessary. Under aseptic condi-
tions, the needle was introduced into the lesion and after
maintaining a negative suction pressure, multiple quick
oscillations in different directions were made till some
material was seen in the hub of the needle. Then the nee-
dle was withdrawn after releasing the negative pressure
gently. One to two more passes were made into the lesion
from different sites to ensure adequate sampling.
The physical nature of the aspirate was noted as fluid, pus,
blood, caseous material and tissue bits etc. to be processed
accordingly. Contents of the needle were blown on clean
glass slides and the smears were made immediately. A few
smears were quickly fixed in 95% ethanol for Hematoxy-
lin and Eosin staining while the remaining smears were air
dried and fixed in methanol for May Grnwald Giemsa
staining. If sufficient material was left after preparing the
smears, cell blocks were also prepared. In addition to the
above mentioned routine stains; cytochemical stains like
reticulin (Gomori's), alkaline phosphatase, Periodic acid
Schiff (PAS) with without diastase, mucicarmine and
immunohistochemical (IHC) stains were employed to
support the diagnosis wherever necessary.
Cytodiagnostic light microscopy was embarked upon; all
the smears were meticulously interpreted by two experi-
enced cytopathologists. Accordingly, the smears were cat-
egorized as "benign", "malignant", "suspicious" and
"inadequate\inconclusive". There was no perfect or abso-
lute morphological feature of cancer, which when present
unequivocally, meant that the cell is cancerous or when
absent means that there was no cancer: however certain
features, when taken in their totality and keeping in view
the clinico-radiological findings enabled the cytopatholo-
gist to divide the cytologic findings into benign, suspi-
cious and malignant. The smears were categorized as
"suspicious" when the specimen was hypocellular and a
few neoplastic cells were present or the cytological fea-
tures of malignancy could not be ruled out conclusively
and "inadequate\inconclusive" category was assigned
when the specimens were extremely paucicellular or
blood mixed to an extent that all other elements were
obscured. The criteria used for labeling the aspirates as
benign and malignant are depicted in Table 1. Wherever
possible, an attempt was made to render an exact cytolog-
ical diagnosis.
For histopathological examination, tissues were embed-
ded in paraffin blocks, sliced into 2–3 micron sections
Table 1: Criteria used in differentiating benign and malignant cytology.
Benign Malignant
Nuclear membrane Smooth Irregular
Chromatin Even General disarray
Nucleolus Not prominent Enlarged, irregular and sharply angled
Mitosis Abnormal mitosis
Nucleo- Cytoplasmic ratio Normal or low HighCytoJournal 2007, 4:9 http://www.cytojournal.com/content/4/1/9
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and stained with routine Hematoxylin and Eosin staining
and examined in a double blind fashion by two patholo-
gists. In case of discrepancy, the opinion of a third pathol-
ogist was taken and two concordant diagnoses were
treated as final.
The findings of FNAB were correlated with the histopatho-
logical diagnosis. Taking histopathology as the "gold
standard" the diagnostic indices were calculated in terms
of true and false positive, true and false negative, sensitiv-
ity, specificity, predictive values and accuracy test to sup-
port our study design. Calculation of these values was
based on cases interpreted as diagnostic on histology,
excluding both the inadequate\inconclusive smears as
well as suspicious category.
A step-wise approach to FNAB diagnosis of bony lesions is
given as follows:
Step 1: Establish category of clinical presentation
A patient may present with a bony mass/es under the fol-
lowing clinical scenarios: (i) Routine medical check-up,
(ii) Bony pain, swelling or discharging sinus (iii) Known
malignant cases. Important relevant data include age of
the patient and site of involvement. Radiologic correla-
tion is mandatory.
Step 2: Establish category of radiologic findings
In many instances, a preoperative diagnosis can be
achieved with a high degree of accuracy based on non-
invasive imaging techniques and close clinical correlation.
FNAB is useful in defining those lesions without charac-
teristic imaging appearance. Lists of entities along with the
cytologic and radiological findings are given as a working
guide. [see Additional file 1]
Step 3: Establish nature of cytohistologic findings.
Usual cytological findings are summarized in the "addi-
tional table".
Step 4: Further confirm nature of cytohistologic findings
The initial cytologic assessment is crucial as it forms the
basis upon which ancillary tests are ordered; the results of
which should be interpreted in the larger context of the
case. Special stains and IHC may be helpful. A whole bat-
tery of antibodies is available for the comparative immu-
nohistochemical study of primary and metastatic bone
tumors, specially utilizing cell block preparations. The
two major diagnostic issues are (i) whether the cells are
malignant or benign? (ii) what is the histogenesis of the
malignant cells? For example osteosarcoma exhibit strong
positivity for Vimentin, variable for Actin/Desmin and S-
100, if chondroid differentiation is present.
Step 5: Establish final diagnosis based on multidiscipli-
nary approach
Close clinicopathological correlation is mandatory for
enhancing the yield of FNAB diagnoses and the reduction
of indeterminate reports.
A diagnostic algorithm for FNAB diagnosis of long bone
lesions is given in Fig. 1, spine in Fig. 2 and skull in Fig. 3.
Results
FNAB categories of 91 cases are summarized in Table 2. Of
91 cases, 81 (89%) were considered satisfactory and 10
(10.9%) were considered inadequate\inconclusive for
diagnosis. The correlation of the diagnosis from FNAB
and Histopathological examination (HPE) in 65 cases is
shown in Table 3. Subsequent HPE was available for 65
(71.4%) of 91 cases, including 36 cases (76.6%) of 47 that
were labeled cytologically benign, 3 (75%) of 4 that were
labeled suspicious on cytology, 16 (53.3%) of 30 that
were malignant on FNAB and all 10 cases in the inade-
quate\insufficient category. In the cytologically suspicious
category, on histopathology, 2 cases (66.7%) out of 3
were found to be malignant. The sensitivity of FNAB was
93.3%, specificity 94.5%, positive predictive value 87.5%
and negative predictive value 97.2%. The diagnostic accu-
racy was 94.23%. Of the 36 cases reported as benign on
cytology, 1 proved to be malignant on histology, giving a
false negative diagnosis. Of the 16 cases reported as malig-
nant on cytology, 2 were later diagnosed as benign on his-
tology, resulting in a false positive diagnosis.
A diagnostic algorithm for FNAB diagnosis of long bone  lesions spine in Fig. 2 and skull in Fig. 3 Figure 1
A diagnostic algorithm for FNAB diagnosis of long bone 
lesions spine in Fig. 2 and skull in Fig. 3.CytoJournal 2007, 4:9 http://www.cytojournal.com/content/4/1/9
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Table 4 shows cases correctly diagnosed on cytology. The
cytodiagnosis included two cases of chondromyxoid
fibroma (Fig. 4), haemangiopericytoma (Fig. 5), tubercu-
losis (Fig. 6), metastatic carcinoma (Fig. 7), Ewing's tumor
(Fig. 8) and myeloma (Fig. 9).
In 48 benign lesions, discordant diagnoses were made in
3 cases. They included 2 cases of chronic granulomatous
bone disease which, on FNAB, appeared to be metastatic
adenocarcinoma, the discrepancy was due to macro-
phages on cytology being misinterpreted for mucin rich
cells. In retrospect, PAS staining was found to be negative
in these cases and a diagnosis of metastatic adenocarci-
noma was refuted. In addition, a case of giant cell repara-
tive granuloma was wrongly diagnosed as giant cell tumor
on cytology (Fig. 10).
Of the 17 malignant lesions, 14 were diagnosed as malig-
nant, 2 as "suspicious" and 1 as benign on cytology. All
the inadequate/inconclusive smears were found to be
benign on histology. The single discordant diagnosis was
seen in a case where a diagnosis of osteochondroma on
cytology was found to be an osteosarcoma on histopa-
thology. (Fig. 11)
Discussion
Martin and Ellis first applied this technique to the diagno-
sis of bone lesions in 1930 [4]. Agarwal et al [5] and Lay-
field et al [6] have done pioneering work in describing the
diagnostic accuracy and clinical utility of fine needle aspi-
ration cytology in the diagnosis of clinically suspected pri-
mary bone tumors. As presurgical chemotherapy has
become the standard treatment for osteosarcoma, FNAB
has gained importance in recent years as an appealing
diagnostic method [7].
Several published series have yielded overall accuracy val-
ues ranging from 51% to 100% (Table 5) [3-33]. This
study differs from previous ones since it explores he utility
of FNAB as the first pathological investigation in the diag-
nostic armamentarium of bony lesions. Of the 91
patients, histological confirmation was available for 65
patients. The sensitivity of FNAB was found to be 93.3%,
specificity 94.5%, positive predictive value 87.5% and
negative predictive value 97.2%. Diagnostic accuracy, on
the other hand, was 94.23%. Similarly, Agarwal et al [5]
reported the FNAB findings in 226 cases of bone tumors.
A specific morphologic diagnosis on FNAB was possible
in 159 cases with one false positive and 29 false negative
reports. Giant cell tumor (32%) and Ewing's sarcoma
(22%) were the most common bone tumors encountered.
In their series, the overall sensitivity and specificity was
86% and 94.7% respectively. The positive predictive value
was as high as 99.4% while the negative predictive value
was 38.3%. They reported that the diagnosis of malignant
tumors was more accurate with positive predictive value
of 99.2% [5]. In our series, the only false negative case was
that of osteosarcoma which was misinterpreted as osteo-
chondroma. On review, it was found that paucicellular
material on aspiration, erroneous cytological interpreta-
tion of cartilaginous components and bony trabeculae,
along with lack of clinico-radiological correlation was the
reason for error and such a smear should have been ide-
ally kept under "inadequate\insufficient" category.
We encountered 2 false positive cases. One case of chronic
granulomatous bone lesion was erroneously diagnosed as
metastatic adenocarcinoma with unknown primary. On
review, this case showed a few large bizarre cells filled
with mucin, which was subsequently found to be macro-
phages. Detailed clinical history, examination and radio-
logical findings were not available at the time of FNAB. It
was found that, when in doubt, adjunct stains like cyto-
chemical and immunocytochemical markers helped in
A diagnostic algorithm for FNAB diagnosis of long bone  lesions skull Figure 3
A diagnostic algorithm for FNAB diagnosis of long bone 
lesions skull.
A diagnostic algorithm for FNAB diagnosis of long bone  lesions spine in Fig. 2 Figure 2
A diagnostic algorithm for FNAB diagnosis of long bone 
lesions spine in Fig. 2CytoJournal 2007, 4:9 http://www.cytojournal.com/content/4/1/9
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reaching a diagnosis. The other case was that of a giant cell
tumor, from an elderly male with a lytic lesion of the dis-
tal humerus, which was misdiagnosed as a sarcoma (not
otherwise specified). Radiological information was again
not available at the time of the diagnosis. The cause of
false positive diagnosis was an interpretive error where
benign cells were misinterpreted as malignant. This fur-
ther underlined the importance of clinico-radiological
correlation in cytology. In our series, only one metastatic
malignancy was found and it was correctly diagnosed. An
appropriate diagnosis of a metastatic lesion by FNAB has
been reported to facilitate either non-operative manage-
ment as well as contemporary surgical reconstructive tech-
niques [30].
We also analyzed the diagnostic limitations of the tech-
nique and specimen adequacy in our study group: "inad-
equate\inconclusive" smears were 10.9%. Most of these
cases were osteosclerotic and fibro-osseous lesions due to
frequent dry taps and inconclusive smears. FNAB has a
limited role in diagnosing these lesions. However, an
experienced aspirator (preferably the cytopathologist, as
in our series), correct aspiration technique and proper
radiological evaluation to locate the most appropriate site
for adequate sampling may minimize chances of inade-
quate material being aspirated. This failure rate was con-
sistent with rates of 1.4 – 33% reported by previous
investigators [30-32].




No. of Cases No. with 100% 
Cyto- histological 
concordance
Benign Suspicious Malignant Inadequate
Non Ossifying Fibroma 2 - - - - 2
Giant Cell Tumor 17 16 16 - 1 -
Osteomyelitis 3 3 3 - - -
Osteochondroma 4 2 2 2 - -
Aneurysmal Bone Cyst 3 3 3 - - -
Osteoid Osteoma 2 - - - - 2
Chondroma 2 2 2 - - -
E n d o s t o s i s 111 - - -
Metaphyseal Fibrous Defect 1 - - - - 1
Osteofibrous Dysplasia 2 - - - - 2
Ameloblastic Fibroma 1 - - - - 1
Giant Cell Reparative Granuloma 1 - - 1 - -
Cavernous Haemangioma 1 - - - - 1
TB Osteomyelitis 3 2 2 - 1 -
Enchondroma 1 1 1 - - -
N o r m a l  B o n e 1 - ---1
Hemangioendothelioma 1 1 1 - - -
Hemangiopericytoma 1 1 1 - - -
Chondromyxoid Fibroma 2 2 2 - - -
• MALIGNANT
Osteosarcoma 7 6 1 - 6 -
Ewing's Sarcoma 4 4 - - 4 -
Metastatic Adenocarcinoma 1 1 - - 1 -
Chondrosarcoma 2 2 - - 2 -
Plasmacytoma 2 2 - - 2 -
TOTAL 65 49 35 3 17 10
Table 2: Cytohistological correlation in 65 bone lesions
Cytological Diagnosis No. of cases with FNAB No. of cases with 
histopathology
No. of benign cases No of Malignant cases
Benign 47 36 35 01
Suspicious 4 03 01 02
Malignant 30 16 02 14
Inadequate\Insufficient 10 10 10 0
T o t a l 9 16 54 81 7CytoJournal 2007, 4:9 http://www.cytojournal.com/content/4/1/9
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The separation of low-grade chondrosarcoma from
enchondroma (chondroma) is an important issue but
since there were only 2 cases in this series, this issue could
not be addressed. Layfield et al have divided chondrosar-
coma into three grades depending on the proportion of
chondroid and myxoid substance as well as the degree of
anaplasia [6]. Similarly, Rinas et al, in a recent report,
have elucidated the difficulties in sampling errors and
diagnosis of dedifferentiated chondrosarcoma [33].
In recent years, cytogenetics has been helping investiga-
tors to understand the genesis of the various bone lesions.
This field is still in its infancy but cytopathologists, the
world over, now recognize the fact that presence of certain
chromosomal aberrations worsens the overall prognosis
and survival post- therapeutic intervention in few bone
tumors. For example, gain of chromosome 8q23 and
CDK4 alone or together with MDM2 is associated with
poor prognosis in osteosarcoma [34]. Similarly rearrange-
ment in band 8q21 is detected exclusively in aggressive
chondroblastoma [35]. More and more such associations
are being discovered daily in research labs world over.
However, cytogenetics was not applied in the cases under
the present study but their importance, as an additional
1. Cells showing coarse purplish granules in the cytoplasm  [MGG; ×1000] Figure 4
1. Cells showing coarse purplish granules in the cytoplasm 
[MGG; ×1000]. 2. Plasmacytoid tumor cells. [H&E; ×1000]. 3. 
Cell block preparation of osteosarcoma: [H&E; ×200].




No. with specific cytological 
diagnosis was rendered.
Non Ossifying Fibroma -
Giant Cell Tumor 16
Osteomyelitis 3
Osteochondroma 2




Metaphyseal Fibrous Defect -
Osteofibrous Dysplasia -
Ameloblastic Fibroma -














TOTAL 49CytoJournal 2007, 4:9 http://www.cytojournal.com/content/4/1/9
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investigative tool in future cannot be understated and a
future study is planned to explore its relevance.
The risks of open biopsy include infection, bleeding
(especially in metastases from renal carcinoma), weaken-
ing of the bone possibly leading to pathological fractures,
contamination of surrounding soft tissues as well as
trauma and anxiety associated with surgery. These disad-
vantages can be avoided if FNAB is performed as an initial
investigation. Ruhs et al found FNAB to be more cost-
effective than open biopsy [36]. Similarly, Bommer et al,
in their elegant study, have demonstrated that initiating
the investigations of bony lesion with FNAB results in
considerable savings. The cost of an open biopsy in the
USA has been estimated to be $US5300 as compared with
$US1600 for FNAB, if both are carried out as outpatient
procedures. In this day of increasing health care costs, this
more than three fold cost difference itself can be an
important consideration [37].
1. Giant cell tumor like picture of giant cell reparative granu- loma [MGG; ×400] Figure 6
1. Giant cell tumor like picture of giant cell reparative granu-
loma [MGG; ×400]. 2. Giant cell reparative granuloma: histo-
logical picture showing giant cells lying in loose stroma. [H&E 
×200]. 3. CT scan of giant cell reparative granuloma showing 
a mass in right maxillary sinus with extension into the adja-
cent areas.
1. Chondroblast like cells embedded in chondroid fragment  in a myxoid background Figure 5
1. Chondroblast like cells embedded in chondroid fragment 
in a myxoid background. [MGG; ×400].CytoJournal 2007, 4:9 http://www.cytojournal.com/content/4/1/9
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Conclusion
FNAB is a simple and economical technique that can be
performed as an outpatient procedure, reducing patient
hospitalization and lowering the overall cost of patient
care. Complications are few and multiple specimens can
be obtained without increased morbidity. Treatment with
radiation and/or chemotherapy can be initiated without
any delay. In current orthopedic oncology practice, sur-
geons need to know the type of malignancy present. Oper-
ative approaches as well as the use of preoperative
chemotherapy and radiation therapy depend on the type
of malignancy diagnosed.
When sampling is adequate and radiological findings are
available, FNAB of bone is a highly accurate diagnostic
technique. Inflammatory conditions, benign non-fibrotic
bone lesions as well as primary and metastatic malignant
tumors can be correctly diagnosed. If bony lesions appears
to be fibrotic and difficult to needle with the FNAB tech-
nique, a core or open biopsy may be performed. A defini-
tive pathologic interpretation should never be rendered if
diagnostic material is inadequate or radiologic informa-
tion is not compatible. Therefore, radiologists,
cytopathologists, and orthopedic surgeons must work
together for optimal results to avoid unsatisfactory
smears. We conclude that considering the overall advan-
tages and cost-analysis, FNAB may be suggested as the ini-
tial method of choice for evaluation of bony lesions in
most clinical settings, especially in resource challenged
countries. The final choice should, however, be decided
on the basis of the working clinical diagnosis and the
institutional/personal experience.
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1. Photograph of a patient showing swelling over left shoul- der: later diagnosed as Hemangiopericytoma Figure 8
1. Photograph of a patient showing swelling over left shoul-
der: later diagnosed as Hemangiopericytoma. 2. X-ray show-
ing lesion involving the left clavicle. 3. Smear showing 
malignant round cells radiating from vessels. [MGG ×400]. 4. 
Histological section of the same case showing monomorphic 
round cells radiating from cells [H&E × 200].
1. Smear showing myeloma cells Figure 7
1. Smear showing myeloma cells. [MGG; × 400]. 2. Histopa-
thology section showing dispersed tumor cells many having a 
"clock-face" condensation of chromatin. [H&E × 200].CytoJournal 2007, 4:9 http://www.cytojournal.com/content/4/1/9
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1. Epithelioid granuloma of tubercular osteomyelitis Figure 10
1. Epithelioid granuloma of tubercular osteomyelitis. [MGG 
×400]. 2. X ray right hand from a case of tubercular osteo-
myelitis involving distal portion of 4th metacarpal.
1. Cytology of Ewing's sarcoma Figure 9
1. Cytology of Ewing's sarcoma. [MGG ×200]. 2. Histology of the same.
1. Metastatic adenocarcinoma: Tumors cell arranged in a  glandular pattern [MGG ×400] Figure 11
1. Metastatic adenocarcinoma: Tumors cell arranged in a 
glandular pattern [MGG ×400]. 2. Metastatic adenocarci-
noma: Tumors cell arranged in an acinar pattern. [MGG 
X400].CytoJournal 2007, 4:9 http://www.cytojournal.com/content/4/1/9
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Agarwal et al 19975 200 95%
Bommer et al 199737 427 95%
Jorda et al 20002 308 95%
Agarwal et al 200028 226 86%
Wedin et al 200029 110 93%
Soderlund et al 200411 370 69%
Domanski et al 200519 130 77%
Handa et al 200530 66 93.3%
Nnodu et al 200632 96 87.8%
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